HealthIT Answers November 13, 2025
The medical technology sector has long been characterized as the steady, reliable engine of the life sciences world. A sector offering consistent growth, without the wild volatility and boom-or-bust narratives of biotech or the frothy hype of digital health, it may be seen by some as “vanilla”, but it also has the benefit of being robust.
In a turbulent global economy caused by Trump’s tariffs, the war in Ukraine and friction between the west and China, medtech is now driving a transformative trend: the concentration of massive, “lumpy” investment capital, exemplified by deals like the recently reported $18billion privatization of Hologic by the private equity giants Blackstone and TPG. However, this influx of capital is not being distributed evenly across...
Today's Sponsors
Today's Sponsor